| Title: | Liver eQTL meta-analysis illuminates potential molecular mechanisms of cardiometabolic traits |
| Journal: | American Journal of Human Genetics |
| Published: | 18 Aug 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39173627/ |
| DOI: | https://doi.org/10.1016/j.ajhg.2024.07.017 |
Publication 13150
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Understanding the molecular mechanisms of complex traits is essential for developing targeted interventions. We analyzed liver expression quantitative-trait locus (eQTL) meta-analysis data on 1,183 participants to identify conditionally distinct signals. We found 9,013 eQTL signals for 6,564 genes; 23% of eGenes had two signals, and 6% had three or more signals. We then integrated the eQTL results with data from 29 cardiometabolic genome-wide association study (GWAS) traits and identified 1,582 GWAS-eQTL colocalizations for 747 eGenes. Non-primary eQTL signals accounted for 17% of all colocalizations. Isolating signals by conditional analysis prior to coloc resulted in 37% more colocalizations than using marginal eQTL and GWAS data, highlighting the importance of signal isolation. Isolating signals also led to stronger evidence of colocalization: among 343 eQTL-GWAS signal pairs in multi-signal regions, analyses that isolated the signals of interest resulted in higher posterior probability of colocalization for 41% of tests. Leveraging allelic heterogeneity, we predicted causal effects of gene expression on liver traits for four genes. To predict functional variants and regulatory elements, we colocalized eQTL with liver chromatin accessibility QTL (caQTL) and found 391 colocalizations, including 73 with non-primary eQTL signals and 60 eQTL signals that colocalized with both a caQTL and a GWAS signal. Finally, we used publicly available massively parallel reporter assays in HepG2 to highlight 14 eQTL signals that include at least one expression-modulating variant. This multi-faceted approach to unraveling the genetic underpinnings of liver-related traits could lead to therapeutic development.</p>
13 Authors
- K Alaine Broadaway
- Sarah M Brotman
- Jonathan D Rosen
- Kevin W Currin
- Abdalla A Alkhawaja
- Amy S Etheridge
- Fred Wright
- Paul Gallins
- Dereje Jima
- Yi-Hui Zhou
- Michael I Love
- Federico Innocenti
- Karen L Mohlke
Enabling scientific discoveries that improve human health